Related references
Note: Only part of the references are listed.Cancer statistics, 2020
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2020)
Association of Chemotherapy With Survival in Elderly Patients With Multiple Comorbidities and Estrogen Receptor-Positive, Node-Positive Breast Cancer
Nina Tamirisa et al.
JAMA ONCOLOGY (2020)
Optimizing adjuvant endocrine therapy for early ER plus breast cancer: An update for surgeons
Umar Wazir et al.
AMERICAN JOURNAL OF SURGERY (2019)
Once-weekly hypofractionated radiotherapy for breast cancer: First results of a phase II clinical trial
Lievin Matos Reboucas et al.
BREAST JOURNAL (2019)
Neoadjuvant Trastuzumab Emtansine and Pertuzumab in Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer: Three-Year Outcomes From the Phase III KRISTINE Study
Sara A. Hurvitz et al.
JOURNAL OF CLINICAL ONCOLOGY (2019)
Randomized Trial of Standard Adjuvant Chemotherapy Regimens Versus Capecitabine in Older Women With Early Breast Cancer: 10-Year Update of the CALGB 49907 Trial
Hyman B. Muss et al.
JOURNAL OF CLINICAL ONCOLOGY (2019)
Breast cancer statistics, 2019
Carol E. DeSantis et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2019)
Utility of a chemotherapy toxicity prediction tool for older patients in a community setting
C. Mariano et al.
CURRENT ONCOLOGY (2019)
External beam accelerated partial breast irradiation versus whole breast irradiation after breast conserving surgery in women with ductal carcinoma in situ and node-negative breast cancer (RAPID): a randomised controlled trial
Timothy J. Whelan et al.
LANCET (2019)
Toxicity of Extended Adjuvant Therapy With Aromatase Inhibitors in Early Breast Cancer: A Systematic Review and Meta-analysis
Hadar Goldvaser et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2018)
Early Breast Cancer in the Elderly: Characteristics, Therapy, and Long-Term Outcome
Omer Gal et al.
ONCOLOGY (2018)
Toxicity of Extended Adjuvant Therapy With Aromatase Inhibitors in Early Breast Cancer: A Systematic Review and Meta-analysis
Hadar Goldvaser et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2018)
Optimal sequence of adjuvant endocrine and radiation therapy in early-stage breast cancer - A systematic review
S. F. McGee et al.
CANCER TREATMENT REVIEWS (2018)
Quality-of-life results for accelerated partial breast irradiation with interstitial brachytherapy versus whole-breast irradiation in early breast cancer after breast-conserving surgery (GEC-ESTRO): 5-year results of a randomised, phase 3 trial
Rebekka Schaefer et al.
LANCET ONCOLOGY (2018)
Single fraction of accelerated partial breast irradiation in the elderly: early clinical outcome
Remy Kinj et al.
RADIATION ONCOLOGY (2018)
Association between adjuvant chemotherapy and risk of acute kidney injury in elderly women diagnosed with early-stage breast cancer
Shuling Li et al.
BREAST CANCER RESEARCH AND TREATMENT (2017)
Adjuvant chemotherapy and HER-2-directed therapy for early-stage breast cancer in the elderly
J. Sun et al.
BRITISH JOURNAL OF CANCER (2017)
Predictors of cognitive decline in people with cancer undergoing chemotherapy
Pok-Ja Oh
EUROPEAN JOURNAL OF ONCOLOGY NURSING (2017)
Highly Accelerated Irradiation in 5 Fractions (HAI-5): Feasibility in Elderly Women With Early or Locally Advanced Breast Cancer
Chris Monten et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2017)
Comparative Toxicity and Effectiveness of Trastuzumab-Based Chemotherapy Regimens in Older Women With Early-Stage Breast Cancer
Katherine E. Reeder-Hayes et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
Disparities in the Initial Local Treatment of Older Women with Early-Stage Breast Cancer: A Population-Based Study
Traci J. LeMasters et al.
JOURNAL OF WOMENS HEALTH (2017)
Partial-breast radiotherapy after breast conservation surgery for patients with early breast cancer (UK IMPORT LOW trial): 5-year results from a multicentre, randomised, controlled, phase 3, non-inferiority trial
Charlotte E. Coles et al.
LANCET (2017)
The benefit of adjuvant radiotherapy after breast conserving surgery in older patients with low risk breast cancer- a meta- analysis of randomized trials
Christiane Matuschek et al.
RADIATION ONCOLOGY (2017)
Tamoxifen with radiotherapy compared with Tamoxifen alone in elderly women with early-stage breast cancer treated with breast conserving surgery: A systematic review and meta-analysis
Tyler R. Chesney et al.
RADIOTHERAPY AND ONCOLOGY (2017)
Omission of axillary staging in elderly patients with early stage breast cancer impacts regional control but not survival: A systematic review and meta-analysis
Shuyin Liang et al.
JOURNAL OF GERIATRIC ONCOLOGY (2017)
Surveillance Mammography in Older Patients With Breast Cancer-CanWe Ever Stop?
Rachel A. Freedman et al.
JAMA ONCOLOGY (2017)
Association of Patient AgeWith Outcomes of Current-Era, Large-Scale Screening Mammography: Analysis of Data From the National Mammography Database
Cindy S. Lee et al.
JAMA ONCOLOGY (2017)
The Chemotherapy Risk Assessment Scale for High-Age Patients (CRASH) score: Design and validation.
M. Extermann et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
Does lymph node status influence adjuvant therapy decision-making in women 70 years of age or older with clinically node negative hormone receptor positive breast cancer?
Anees B. Chagpar et al.
AMERICAN JOURNAL OF SURGERY (2017)
Risk of death from cardiovascular disease following breast cancer: a systematic review
S. A. M. Gernaat et al.
BREAST CANCER RESEARCH AND TREATMENT (2017)
What influences healthcare professionals' treatment preferences for older women with operable breast cancer? An application of the discrete choice experiment
J. L. Morgan et al.
EJSO (2017)
Treatment recommendations for older women with breast cancer: A survey among surgical, radiation and medical oncologists
V. C. Hamelinck et al.
EJSO (2017)
Targeted therapy in older women with breast cancer - What's the target?
M. Kiderlen et al.
EJSO (2017)
Comprehensive geriatric assessment for older adults admitted to hospital
Graham Ellis et al.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2017)
The clinical prognostic value of molecular intrinsic tumor subtypes in older breast cancer patients: A FOCUS study analysis
Charla C. Engels et al.
MOLECULAR ONCOLOGY (2016)
Screening for Breast Cancer: US Preventive Services Task Force Recommendation Statement
Albert L. Siu et al.
ANNALS OF INTERNAL MEDICINE (2016)
Early-Stage Breast Cancer in the Octogenarian: Tumor Characteristics, Treatment Choices, and Clinical Outcomes
Anita Mamtani et al.
ANNALS OF SURGICAL ONCOLOGY (2016)
Prognostic impact of breast cancer subtypes in elderly patients
E. S. Bergen et al.
BREAST CANCER RESEARCH AND TREATMENT (2016)
Breast Cancer Subtypes in Patients Aged 70 Years and Older
Robert Konigsberg et al.
CANCER INVESTIGATION (2016)
A Prospective Comparison of Younger and Older Patients' Preferences for Adjuvant Chemotherapy and Hormonal Therapy in Early Breast Cancer
Victoria C. Hamelinck et al.
CLINICAL BREAST CANCER (2016)
Adjuvant Radiation Improves Survival in Older Women Following Breast-Conserving Surgery for Estrogen Receptor-Negative Breast Cancer
Emily C. Daugherty et al.
CLINICAL BREAST CANCER (2016)
Radiotherapy in Patients 70 Years and Older With Triple-Negative Breast Cancer
Ozer Algan et al.
CLINICAL BREAST CANCER (2016)
Adjuvant chemotherapy in elderly patients with primary breast cancer: are women aparts per thousandyen65 undertreated?
C. W. Wallwiener et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2016)
Effect of Pretreatment Renal Function on Treatment and Clinical Outcomes in the Adjuvant Treatment of Older Women With Breast Cancer: Alliance A171201, an Ancillary Study of CALGB/CTSU 49907
Stuart M. Lichtman et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
American Cancer Society/American Society of Clinical Oncology Breast Cancer Survivorship Care Guideline
Carolyn D. Runowicz et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
Breast reconstruction in older patients: A literature review of the decision-making process
K. E. Hamnett et al.
JOURNAL OF PLASTIC RECONSTRUCTIVE AND AESTHETIC SURGERY (2016)
5-year results of accelerated partial breast irradiation using sole interstitial multicatheter brachytherapy versus whole-breast irradiation with boost after breast-conserving surgery for low-risk invasive and in-situ carcinoma of the female breast: a randomised, phase 3, non-inferiority trial
Vratislav Strnad et al.
LANCET (2016)
Short-course radiotherapy in elderly women with breast cancer: Comparison by age, comorbidity index and toxicity
Francesca Maria Giugliano et al.
INTERNATIONAL JOURNAL OF SURGERY (2016)
Intraoperative radiotherapy in elderly patients with breast cancer: Is there a clinical applicability? Review of the current evidence
Emanuela Esposito et al.
INTERNATIONAL JOURNAL OF SURGERY (2016)
The impact of adjuvant chemotherapy in older breast cancer patients on clinical and biological aging parameters
Barbara Brouwers et al.
ONCOTARGET (2016)
Optimal breast cancer screening strategies for older women: current perspectives
Dejana Braithwaite et al.
CLINICAL INTERVENTIONS IN AGING (2016)
Breast Cancer in Women Older Than 80 Years
Shlomit Strulov Shachar et al.
JOURNAL OF ONCOLOGY PRACTICE (2016)
Comparative adherence to oral hormonal agents in older women with breast cancer
Winson Y. Cheung et al.
BREAST CANCER RESEARCH AND TREATMENT (2015)
A Randomized Phase 2 Study Comparing EC or CMF Versus Nab-Paclitaxel Plus Capecitabine as Adjuvant Chemotherapy for Nonfrail Elderly Patients With Moderate to High-Risk Early Breast Cancer (ICE II-GBG 52)
Gunter von Minckwitz et al.
CANCER (2015)
The evolving role of adjuvant radiotherapy for elderly women with early-stage breast cancer
Charles E. Rutter et al.
CANCER (2015)
A systematic review of factors influencing older adults' decision to accept or decline cancer treatment
Martine T. E. Puts et al.
CANCER TREATMENT REVIEWS (2015)
Comparison of Adjuvant Radiation Therapy Alone Versus Radiation Therapy and Endocrine Therapy in Elderly Women With Early-Stage, Hormone Receptor-Positive Breast Cancer Treated With Breast-Conserving Surgery
Colin T. Murphy et al.
CLINICAL BREAST CANCER (2015)
Healthcare professionals' preferences for surgery or primary endocrine therapy to treat older women with operable breast cancer
J. L. Morgan et al.
EJSO (2015)
Surgery improves survival in elderly with breast cancer. A study of 465 patients in a single institution
T. Cortadellas et al.
EJSO (2015)
Omission of radiotherapy in elderly patients with early breast cancer: 15-Year results of a prospective non-randomised trial
Gabriele Martelli et al.
EUROPEAN JOURNAL OF CANCER (2015)
Benefits and Harms of Breast Cancer Screening A Systematic Review
Evan R. Myers et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2015)
Breast Cancer Screening for Women at Average Risk 2015 Guideline Update From the American Cancer Society
Kevin C. Oeffinger et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2015)
Tumor Marker Usage and Medical Care Costs Among Older Early-Stage Breast Cancer Survivors
Scott D. Ramsey et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
Breast-conserving surgery with or without irradiation in women aged 65 years or older with early breast cancer (PRIME II): a randomised controlled trial
Ian H. Kunkler et al.
LANCET ONCOLOGY (2015)
Adjuvant Paclitaxel and Trastuzumab for Node-Negative, HER2-Positive Breast Cancer
Sara M. Tolaney et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Hypofractionated irradiation in elderly patients with breast cancer after breast conserving surgery and mastectomy : Analysis of 205 cases
Melanie Dore et al.
RADIATION ONCOLOGY (2015)
Trastuzumab in the treatment of elderly patients with early breast cancer: Results from an observational study in Germany
Peter Dall et al.
JOURNAL OF GERIATRIC ONCOLOGY (2015)
Falls in Older Adults With Cancer: Evaluation by Oncology Providers
Emily J. Guerard et al.
JOURNAL OF ONCOLOGY PRACTICE (2015)
Weekly docetaxel versus CMF as adjuvant chemotherapy for older women with early breast cancer: final results of the randomized phase III ELDA trial
F. Perrone et al.
ANNALS OF ONCOLOGY (2015)
The Use of Adjuvant Radiotherapy in Elderly Patients With Early-Stage Breast Cancer: Changes in Practice Patterns After Publication of Cancer and Leukemia Group B 9343
Manisha Palta et al.
CANCER (2015)
Lumpectomy Plus Tamoxifen With or Without Irradiation in Women Age 70 Years or Older With Early Breast Cancer: Long-Term Follow-Up of CALGB 9343
Kevin S. Hughes et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
Trastuzumab-Related Cardiotoxicity Among Older Patients With Breast Cancer
Mariana Chavez-MacGregor et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
Early Breast Cancer in the Older Woman
Ari VanderWalde et al.
CLINICS IN GERIATRIC MEDICINE (2012)
Incidence of Heart Failure or Cardiomyopathy After Adjuvant Trastuzumab Therapy for Breast Cancer
Jersey Chen et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2012)
Management of elderly patients with breast cancer: updated recommendations of the International Society of Geriatric Oncology (SIOG) and European Society of Breast Cancer Specialists (EUSOMA)
Laura Biganzoli et al.
LANCET ONCOLOGY (2012)
Weekly nab-paclitaxel is safe and effective in ≥65 years old patients with metastatic breast cancer: A post-hoc analysis
Matti Aapro et al.
BREAST (2011)
Adjuvant docetaxel/cyclophosphamide in breast cancer patients over the age of 70: Results of an observational study
Gilles Freyer et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2011)
BREAST-CONSERVING TREATMENT IN THE ELDERLY: LONG-TERM RESULTS OF ADJUVANT HYPOFRACTIONATED AND NORMOFRACTIONATED RADIOTHERAPY
Youlia M. Kirova et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2009)
Docetaxel With Cyclophosphamide Is Associated With an Overall Survival Benefit Compared With Doxorubicin and Cyclophosphamide: 7-Year Follow-Up of US Oncology Research Trial 9735
Stephen Jones et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
The Vulnerable Elders-13 Survey Predicts 5-Year Functional Decline and Mortality Outcomes in Older Ambulatory Care Patients
Lillian Min et al.
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY (2009)
Congestive heart failure in older women treated with adjuvant anthracycline chemotherapy for breast cancer
Mary C. Pinder et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Trastuzumab treatment and the risk of central nervous system (CNS) metastases
M. C. Pinder et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Use and outcomes of adjuvant chemotherapy in older women with breast cancer
Sharon H. Giordano et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Adjuvant chemotherapy and survival in older women with hormone receptor-negative breast cancer: Assessing outcome in a population-based, observational cohort
Elena B. Elkin et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Radiotherapy omission after breast-conserving surgery is associated with reduced breast cancer-specific survival in elderly women with breast cancer
Pauline T. Truong et al.
AMERICAN JOURNAL OF SURGERY (2006)
Trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer
MJ Piccart-Gebhart et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Disease-free survival advantage of weekly epirubicin plus tamoxifen versus tamoxifen alone as adjuvant treatment of operable, node-positive, elderly breast cancer patients:: 6-year follow-up results of the French Adjuvant Study Group 08 Trial
P Fargeot et al.
JOURNAL OF CLINICAL ONCOLOGY (2004)
Undertreatment strongly decreases prognosis of breast cancer in elderly women
C Bouchardy et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
Burdens and benefits of adjuvant cyclophosphamide, methotrexate, and fluorouracil and tamoxifen for elderly patients with breast cancer:: The International Breast Cancer Study Group Trial VII
D Crivellari et al.
JOURNAL OF CLINICAL ONCOLOGY (2000)